snakemarket.com
Snake Market

China Biotech Week in Review: Deals Abound

chinabiotodaynewlogoChinaBio Today submits:

Sichuan Kelun Pharmaceutical [SZEX: 002422], a major manufacturer of IV solutions, announced its plans to raise 5 billion RMB ($735 million) in an IPO on the Shenzhen exchange (see story). The company will issue 60 million A-shares, about 25% of its outstanding shares, at a price of 83.36 RMB ($12.26). Founded in 1996, Kelun’s revenues topped $382 million in 2008. Taxable profit was $88 million.

GanLee Pharmaceutical Company Limited, a Beijing biopharma that produces human recombinant insulin and insulin analog products, has received a 100 million RMB ($15 million) investment from Qiming Venture Partners (see story). GanLee will use the capital to increase R&D, manufacturing and sales and marketing.


Complete Story »

Read More

Add to Yahoo MyWeb Add to Yahoo Buzz Add to Yahoo Bookmarks Stumble on StumbleUpon Add to Reddit Add to Google Bookmarks Add to Newsvine Add to MySpace Add to Windows Live Add to Furl Add to Fark Add to Facebook Submit to Digg Add to Delicious Add to Blinklist

Comment on "China Biotech Week in Review: Deals Abound"

Your Name

Your Comments

Verification Code: 418B9
Enter Code:






Privacy Policy | Copyright/Trademark Notification